Pharma project delays are rarely caused by a single big failure. They are the cumulative result of small, ignored issues at design, vendor selection, and execution stages. Recognising the early signals is the difference between on-time commissioning and a 6-month slip.
1. Incomplete URS at Concept Stage
An incomplete User Requirement Specification is the single biggest reason for downstream design changes. Every change after engineering freeze cascades into vendor re-quotes, layout edits, and validation re-runs.
2. Wrong Vendor Selection
- Selecting on lowest price instead of pharma capability
- Skipping vendor capability audits
- Ignoring past performance and reference checks
3. Poor Inter-Disciplinary Coordination
Civil, mechanical, electrical, HVAC, and instrumentation teams working in silos create interface conflicts that surface only at site — by which time, rework is expensive.
4. Inadequate Long-Lead Item Planning
AHUs, chillers, custom skids, and validation instruments have 16–24 week lead times. Ordering them based on detailed engineering instead of concept-stage commitment is a common cause of 2–3 month slippages.
5. Ignoring Change Control
Uncontrolled scope changes during execution — driven by user departments, marketing, or board direction — derail the critical path. Strong change-control discipline is non-negotiable.
How to Prevent It
- Lock URS before engineering — and resist mid-project changes
- Run vendor capability audits before order placement
- Conduct weekly interface review meetings across disciplines
- Pre-commit long-lead items at concept stage
- Empower PMC to enforce change control discipline
Conclusion
Project delays are a leadership problem before they are a technical problem. The fix is upstream discipline — not downstream firefighting.
At H&G, our Pharma Engineering & PMC practice has executed projects across Indian and overseas geographies with on-time and audit-clean track record. Contact us for project recovery, planning, or PMC support.